
# Figures and Tables

**Manuscript Title:** The Looming Crisis of Primary Drug Resistance: A Multi-Model Forecasting, Meta-Analytical, and Policy Scenario Assessment of Tuberculosis in India (2025–2030)

---

### **List of Figures**

**Figure 1:** National TB Forecast and Policy Analysis. **(A)** Ensemble forecast projecting a rise in notification to ~3.00 million by 2030 (Blue shading: 95% Uncertainty). **(B)** Comparative impact of three intervention scenarios, showing the "Combination Strategy" (Red) achieving a significant decline.

![Figure 1: Forecast and Scenarios](d:/research-automation/tb_amr_project/manuscript_assets/Figure_1_Combined_Forecast_Scenarios.png){width=100%}

\newpage

**Figure 2:** Geographic Distribution of DR-TB Burden (2030). **(A)** Absolute volume of projected cases. **(B)** Intensity of resistance (% of Total), highlighting hotspots like Maharashtra despite lower total volume compared to UP.

![Figure 2: Geographic Hotspots](d:/research-automation/tb_amr_project/manuscript_assets/Figure_2_Chloropleth_Revised.png){width=100%}

\newpage

**Figure 3:** Dynamics of the Drug-Resistant TB Epidemic (2025–2030). **(A)** Trend showing dominance of Primary Resistance (New Cases). **(B)** The Diagnostic Gap in 2030, visualizing ~85,000 missed cases under risk-based screening. **(C)** The Cost of Inaction: Projected deaths/failures averted by universal regimen optimization.

![Figure 3: DR-TB Dynamics](d:/research-automation/tb_amr_project/manuscript_assets/Figure_3_DRTB_Dynamics.png){width=100%}

\newpage

**Figure 4:** Rapid Meta-Analysis Evidence. Forest plot synthesizing recent prevalence studies (2019-2024) to validate the baseline primary resistance rate of ~3.6% used in the forecast model.

![Figure 4: Meta-Analysis Evidence](d:/research-automation/tb_amr_project/manuscript_assets/Figure_4_Rapid_Meta_Analysis.png){width=90%}

\newpage

**Figure 5:** Demographic Profile of TB in High-Burden States. Heatmap showing the concentration of cases in the economically productive 15-45 age groups.

![Figure 5: Demographics](d:/research-automation/tb_amr_project/manuscript_assets/Figure_3_Demographics.png){width=90%}

\newpage

---

### **List of Tables**

**Table 1: Projected Top 10 High-Burden States for Drug-Resistant TB in 2030**

| State | Total Cases (2025) | DR-TB (2025) | Total Cases (2030) | DR-TB (2030) |
| :--- | :--- | :--- | :--- | :--- |
| **Uttar Pradesh** | 670,634 | 33,095 | 877,401 | 48,028 |
| **Bihar** | 216,476 | 10,683 | 283,127 | 15,498 |
| **Maharashtra** | 217,796 | 10,748 | 231,611 | 12,678 |
| **Madhya Pradesh** | 182,475 | 9,005 | 187,591 | 10,268 |
| **Rajasthan** | 171,637 | 8,470 | 180,892 | 9,902 |

*(Full table data in Supplementary Materials)*

\newpage

**Table 2: Comparative Impact of Policy Interventions on 2030 TB Burden**

| Year | Baseline (Status Quo) | Treatment Optimization | Prevention First | Combination Strategy |
| :--- | :--- | :--- | :--- | :--- |
| **2025** | 2,368,508 | 2,321,138 | 2,486,933 | 2,437,195 |
| **2030** | 2,546,029 | 2,255,380 | 1,670,450 | 1,352,541 |

*Values represent estimated total annual notifications.*
